Author

V. Katritch

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

S. A. Zaidi· 2 shared A. A. Peluso· 1 shared A. C. Kruegel· 1 shared A. D. de Kloet· 1 shared A. F. Rodrigues· 1 shared A. Hodges· 1 shared A. Hunkele· 1 shared A. L. Nazarova· 1 shared

Activity by Year

2017-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

S. A. Zaidi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Angiotensin-(1-5) is a Potent Endogenous Angiotensin AT2-Receptor Agonist

I. M. Souza-Silva, A. A. Peluso, K. Elsaafien, A. L. Nazarova, K. B. Assersen, L. Rodrigues-Ribeiro, M. Mohammed, A. F. Rodrigues, A. Nawrocki, L. A. Johansen, P. Jensen, A. D. de Kloet, E. G. Krause, M. DelBorgo, I. Maslov, , U. M. Steckelings

This study identifies angiotensin-(1-5) as a potent endogenous agonist of the AT2-receptor, showing its ability to increase nitric oxide release and lower blood pressure through AT2R-mediated mechanisms.

bioRxiv · Apr 5, 2024 · PreprintPharmacology & Toxicology

Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Addiction States

V. Havel, A. C. Kruegel, B. Bechand, S. McIntosh, L. Stallings, A. Hodges, M. G. Wulf, M. Nelson, A. Hunkele, M. Ansonoff, J. E. Pintar, C. Hwu, N. Abi-Gerges, S. A. Zaidi, V. Katritch, , D. Sames

This paper introduces a new class of iboga alkaloids, oxa-iboga, which show therapeutic efficacy in opioid use disorder without cardiac risks, as demonstrated in rat models.

bioRxiv · Jul 22, 2021 · PreprintPharmacology & Toxicology

Intracellular Passage Of Na+ In An Active State G Protein Coupled Receptor

o. N. Vickery, C. A. Carvalheda, S. A. Zaidi, A. V. Pisliakov, V. Katritch, U. Zachariae

This study shows that Na+ ion movement from an extracellular binding site to the cytosol is a key step in GPCR activation, stabilizing active-state conformations.

bioRxiv · Jul 21, 2017Biophysics